Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · IEX Real-Time Price · USD
2.295
-0.105 (-4.38%)
At close: Jul 19, 2024, 4:00 PM
2.230
-0.065 (-2.83%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $207.28 million as of July 22, 2024. Its market cap has decreased by -43.13% in one year.
Market Cap
207.28M
Enterprise Value
-59.55M
1-Year Change
-43.13%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $207.28M, a decrease of -76.67%. That is a compound annual growth rate of -38.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 207.30M | -59.09% |
| Dec 29, 2023 | 506.70M | 32.26% |
| Dec 30, 2022 | 383.10M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 211.76M |
| Century Therapeutics | 211.25M |
| The Joint | 209.63M |
| Abeona Therapeutics | 209.32M |
| Shattuck Labs | 209.22M |
| Genfit | 207.00M |
| Pyxis Oncology | 204.93M |
| Biodesix | 202.99M |